Back to top
more

Molina Healthcare (MOH)

(Delayed Data from NYSE)

$325.43 USD

325.43
231,999

-4.87 (-1.47%)

Updated Oct 10, 2024 04:00 PM ET

After-Market: $325.51 +0.08 (0.02%) 4:48 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value F Growth D Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 5% (238 out of 250)

Industry: Medical - HMOs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Medtronic (MDT) Global Business Gains Ground, Volume Woes Stay

by Zacks Equity Research

Since the start of fiscal 2022, Medtronic (MDT) has been witnessing a strong recovery and displayed a return to growth.

Thermo Fisher (TMO) End Markets Strong, Margin Under Pressure

by Zacks Equity Research

Thermo Fisher's (TMO) core business strength was broad-based across segments, end markets, and geographies.

Zimmer Biomet (ZBH) Q1 Earnings Top Estimates, FY22 View Up

by Zacks Equity Research

Each of Zimmer Biomet's (ZBH) geographic segments and product divisions recorded year-over-year sales growth at CER.

Catalent (CTLT) Q3 Earnings Beat Estimates, FY22 View Up

by Zacks Equity Research

Catalent's (CTLT) robust performance across most of its segments drives its third-quarter fiscal 2022 top line.

Here's Why You Should Hold on to Edwards Lifesciences (EW) Now

by Zacks Equity Research

Investors are optimistic about Edwards Lifesciences (EW) given the strong demand for its RESILIA tissue valves and the PASCAL system.

Henry Schein (HSIC) Q1 Earnings Top Estimates, Gross Margin Up

by Zacks Equity Research

Robust performances by all three operating segments drove Henry Schein's (HSIC) first-quarter 2022 revenues.

Omnicell (OMCL) Q1 Earnings Top Estimates, Margins Decline

by Zacks Equity Research

Robust sales performance across Omnicell's (OMCL) operating segments has contributed to the first-quarter top line.

Integer Holdings (ITGR) Q1 Earnings, Revenues Lag Estimates

by Zacks Equity Research

Integer Holdings' (ITGR) first-quarter results reflect robust segmental performances besides strength in the majority of the product lines.

ResMed (RMD) Q3 Earnings Miss Estimates, Margins Decline

by Zacks Equity Research

Strong demand for sleep and respiratory care devices contributed to ResMed's (RMD) fiscal third-quarter sales performance.

Community Health (CYH) Q1 Earnings Beat, Trims '22 EPS View

by Zacks Equity Research

Community Health's (CYH) first-quarter results benefit on the back of higher adjusted admissions and reduced interest expense. A lowered 2022 outlook for EPS might be a concern for investors.

Molina Healthcare (MOH) Q1 Earnings Beat on Higher Premiums

by Zacks Equity Research

Molina Healthcare (MOH) boosts premium and bottom-line guidance for 2022, reflecting improving business.

Molina (MOH) Q1 Earnings and Revenues Top Estimates

by Zacks Equity Research

Molina (MOH) delivered earnings and revenue surprises of 3.38% and 3.08%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Is Humana (HUM) a Great Value Stock Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Has Molina Healthcare (MOH) Outpaced Other Medical Stocks This Year?

by Zacks Equity Research

Here is how Molina (MOH) and UnitedHealth Group (UNH) have performed compared to their sector so far this year.

Molina Healthcare (MOH) to Post Q1 Earnings: What's in Store?

by Zacks Equity Research

Molina Healthcare's (MOH) first-quarter results are likely to reflect the benefits of increased membership in the Medicare program.

Molina (MOH) Earnings Expected to Grow: Should You Buy?

by Zacks Equity Research

Molina (MOH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Here's Why Molina (MOH) is a Strong Growth Stock

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Here's How Much You'd Have If You Invested $1000 in Molina a Decade Ago

by Zacks Equity Research

Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.

Should Vanguard S&P MidCap 400 ETF (IVOO) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for IVOO

Molina Healthcare (MOH) Up 32% in a Year: Is More Upside Left?

by Zacks Equity Research

Continued revenue growth, well-performing Medicaid and Medicare businesses, expense saving initiatives and solid cash balance continue to drive Molina Healthcare (MOH).

Molina (MOH) Up 3.3% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research

Molina (MOH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Centene (CNC) Wins Contract to Serve Medicaid Members in Indiana

by Zacks Equity Research

Centene's (CNC) Indiana subsidiary receives a contract from the Indiana Department of Administration, thereby continuing to serve the unique health needs of Indiana communities.

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Should iShares Core S&P MidCap ETF (IJH) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for IJH

Here's How Much You'd Have If You Invested $1000 in Molina a Decade Ago

by Zacks Equity Research

Holding on to popular or trending stocks for the long-term can make your portfolio a winner.